AMAGUnknown
AMAG PHARMACEUTICALS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AMAG PHARMACEUTICALS, INC. (AMAG), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are AMAG insiders buying or selling?
AMAG PHARMACEUTICALS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 15 Form 4 filings for AMAG: 10 buys ($11.4M) and 5 sells ($60.2M).
Source: SEC EDGAR Form 4
Key Statistics (March 2018 – Oct 5, 2020)
Total Form 4 filings
15
SEC EDGAR
Insider filers
6
Insider buys (10)
$11.4M
Insider sells (5)
$60.2M
Insider sentiment
Net sellingNet insider flow of $48.9M in net selling since March 2018.
Recent AMAG insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5, 2020 | Camber Capital Management LP | 10% Owner | Sale | 4.4M | $13.57 | $59.6M | SEC ↗ |
| Mar 18, 2020 | Steven Boyd | 10% Owner | Purchase | 24.0K | $4.87 | $116.9K | SEC ↗ |
| Feb 27, 2020 | Steven Boyd | 10% Owner | Purchase | 36.0K | $8.29 | $298.4K | SEC ↗ |
| Jan 28, 2020 | Steven Boyd | 10% Owner | Purchase | 90.0K | $9.61 | $865.2K | SEC ↗ |
| Jan 13, 2020 | Steven Boyd | 10% Owner | Purchase | 18.0K | $11.57 | $208.3K | SEC ↗ |
| Aug 9, 2019 | Steven Boyd | 10% Owner | Purchase | 300.0K | $7.33 | $2.2M | SEC ↗ |
| Aug 9, 2019 | Camber Capital Management LP | 10% Owner | Purchase | 385.0K | $7.87 | $3.0M | SEC ↗ |
| Jun 27, 2019 | Steven Boyd | 10% Owner | Purchase | 498.0K | $8.87 | $4.4M | SEC ↗ |
| May 29, 2019 | Julie Krop | Chief Medical Officer | Purchase | 10.0K | $9.91 | $99.1K | SEC ↗ |
| May 9, 2019 | William K Heiden | President & CEO | Purchase | 10.0K | $10.70 | $107.0K | SEC ↗ |
| May 9, 2019 | Elizabeth Scott Bolgiano | Chief Human Resources Officer | Purchase | 5.0K | $10.93 | $54.6K | SEC ↗ |
| Mar 11, 2019 | Joseph Vittiglio | EVP, General Counsel | Sale | 1.4K | $14.01 | $20.0K | SEC ↗ |
| Aug 8, 2018 | William K Heiden | President & CEO | Sale | 5.0K | $25.00 | $125.0K | SEC ↗ |
| Jun 5, 2018 | William K Heiden | President & CEO | Sale | 20.0K | $25.00 | $500.0K | SEC ↗ |
| Mar 7, 2018 | Joseph Vittiglio | EVP, General Counsel | Sale | 770 | $20.80 | $16.0K | SEC ↗ |
Showing the 15 most recent of 15 Form 4 filings for AMAG PHARMACEUTICALS, INC..
Most active AMAG insiders
- Steven Boyd6 filings
- William K Heiden3 filings
- Camber Capital Management LP2 filings
- Joseph Vittiglio2 filings
- Elizabeth Scott Bolgiano1 filing
Ask anything about AMAG insider activity
Use Trabud's AI agent to query AMAG PHARMACEUTICALS, INC.'s Form 4 history in plain English — "Show me AMAG CEO purchases this year" or compare it against any other ticker.
Open the AI agentAMAG insider trading FAQ
Are AMAG PHARMACEUTICALS, INC. insiders buying or selling?
AMAG PHARMACEUTICALS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 15 Form 4 filings for AMAG: 10 buys ($11.4M) and 5 sells ($60.2M). Over the full record that is net selling of $48.9M.
How many insiders trade AMAG stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AMAG PHARMACEUTICALS, INC.. The most recent filing was accepted on Oct 5, 2020.
Where does Trabud get AMAG insider trading data?
All AMAG insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.